// Gastrointestinal System - Drugs
// Auto-generated from modularize-data.js

const drugs = [

    {
        "id": "omeprazole",
        "name": "Omeprazole",
        "pharmacologicClass": "proton-pump-inhibitors",
        "therapeuticClass": "acid-suppression",
        "system": "gastrointestinal-system",
        "mechanism": "Irreversibly block H+/K+-ATPase in gastric parietal cells.",
        "features": "First PPI, extensive CYP2C19 metabolism.",
        "clinicalChoice": "GERD, peptic ulcer disease.",
        "indications": [
            "GERD",
            "Peptic Ulcer Disease",
            "H. pylori Eradication"
        ],
        "contraindications": [
            "Clopidogrel (avoid omeprazole)"
        ],
        "sideEffects": [
            "Bone fractures",
            "B12 deficiency",
            "C. diff infection",
            "Rebound acid hypersecretion"
        ],
        "interactions": "Reduce absorption of pH-dependent drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "pantoprazole",
        "name": "Pantoprazole",
        "pharmacologicClass": "proton-pump-inhibitors",
        "therapeuticClass": "acid-suppression",
        "system": "gastrointestinal-system",
        "mechanism": "Irreversibly block H+/K+-ATPase in gastric parietal cells.",
        "features": "IV formulation available.",
        "clinicalChoice": "Upper GI bleeding, ICU stress ulcer prophylaxis.",
        "indications": [
            "Upper GI Bleeding",
            "GERD"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "sideEffects": [
            "Bone fractures",
            "B12 deficiency",
            "C. diff infection",
            "Rebound acid hypersecretion"
        ],
        "interactions": "Reduce absorption of pH-dependent drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "esomeprazole",
        "name": "Esomeprazole",
        "pharmacologicClass": "proton-pump-inhibitors",
        "therapeuticClass": "acid-suppression",
        "system": "gastrointestinal-system",
        "mechanism": "Irreversibly block H+/K+-ATPase in gastric parietal cells.",
        "features": "S-enantiomer of omeprazole.",
        "clinicalChoice": "Erosive esophagitis.",
        "indications": [
            "Erosive Esophagitis",
            "GERD"
        ],
        "contraindications": [
            "Clopidogrel concerns"
        ],
        "sideEffects": [
            "Bone fractures",
            "B12 deficiency",
            "C. diff infection",
            "Rebound acid hypersecretion"
        ],
        "interactions": "Reduce absorption of pH-dependent drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "ranitidine",
        "name": "Ranitidine",
        "pharmacologicClass": "h2-receptor-antagonists",
        "therapeuticClass": "acid-suppression",
        "system": "gastrointestinal-system",
        "mechanism": "Block histamine H2 receptors on gastric parietal cells.",
        "features": "Fewer drug interactions than cimetidine.",
        "clinicalChoice": "GERD, peptic ulcers (when PPI not needed).",
        "indications": [
            "GERD",
            "Peptic Ulcer Disease"
        ],
        "contraindications": [
            "Porphyria"
        ],
        "sideEffects": [
            "CNS effects (especially cimetidine)",
            "Gynecomastia",
            "Drug interactions"
        ],
        "interactions": "Cimetidine inhibits CYP enzymes.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "famotidine",
        "name": "Famotidine",
        "pharmacologicClass": "h2-receptor-antagonists",
        "therapeuticClass": "acid-suppression",
        "system": "gastrointestinal-system",
        "mechanism": "Block histamine H2 receptors on gastric parietal cells.",
        "features": "Longest duration, fewest interactions.",
        "clinicalChoice": "Preferred H2 blocker.",
        "indications": [
            "GERD",
            "Peptic Ulcer Disease"
        ],
        "contraindications": [
            "Renal Impairment"
        ],
        "sideEffects": [
            "CNS effects (especially cimetidine)",
            "Gynecomastia",
            "Drug interactions"
        ],
        "interactions": "Cimetidine inhibits CYP enzymes.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "cimetidine",
        "name": "Cimetidine",
        "pharmacologicClass": "h2-receptor-antagonists",
        "therapeuticClass": "acid-suppression",
        "system": "gastrointestinal-system",
        "mechanism": "Block histamine H2 receptors on gastric parietal cells.",
        "features": "Multiple drug interactions via CYP inhibition.",
        "clinicalChoice": "Avoid due to interactions.",
        "indications": [
            "GERD",
            "Peptic Ulcer Disease"
        ],
        "contraindications": [
            "Multiple drug interactions"
        ],
        "sideEffects": [
            "CNS effects (especially cimetidine)",
            "Gynecomastia",
            "Drug interactions"
        ],
        "interactions": "Cimetidine inhibits CYP enzymes.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "aluminum-hydroxide",
        "name": "Aluminum Hydroxide",
        "pharmacologicClass": "antacids",
        "therapeuticClass": "acid-suppression",
        "system": "gastrointestinal-system",
        "mechanism": "Neutralize gastric acid through basic compounds.",
        "features": "Constipating, phosphate binding.",
        "clinicalChoice": "Hyperphosphatemia in CKD.",
        "indications": [
            "Hyperphosphatemia",
            "Heartburn"
        ],
        "contraindications": [
            "Constipation"
        ],
        "sideEffects": [
            "Constipation (aluminum)",
            "Diarrhea (magnesium)",
            "Electrolyte imbalances"
        ],
        "interactions": "Affect absorption of many drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "magnesium-hydroxide",
        "name": "Magnesium Hydroxide",
        "pharmacologicClass": "antacids",
        "therapeuticClass": "acid-suppression",
        "system": "gastrointestinal-system",
        "mechanism": "Neutralize gastric acid through basic compounds.",
        "features": "Laxative effect.",
        "clinicalChoice": "Heartburn with constipation.",
        "indications": [
            "Heartburn",
            "Constipation"
        ],
        "contraindications": [
            "Renal Impairment",
            "Diarrhea"
        ],
        "sideEffects": [
            "Constipation (aluminum)",
            "Diarrhea (magnesium)",
            "Electrolyte imbalances"
        ],
        "interactions": "Affect absorption of many drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "metoclopramide",
        "name": "Metoclopramide",
        "pharmacologicClass": "prokinetic-agents",
        "therapeuticClass": "gastrointestinal-motility",
        "system": "gastrointestinal-system",
        "mechanism": "Enhance GI motility through various receptor mechanisms.",
        "features": "D2 antagonist, 5-HT4 agonist.",
        "clinicalChoice": "Gastroparesis, postoperative nausea.",
        "indications": [
            "Gastroparesis",
            "Postoperative Nausea"
        ],
        "contraindications": [
            "GI Obstruction",
            "Parkinson Disease"
        ],
        "sideEffects": [
            "Extrapyramidal effects",
            "Tardive dyskinesia",
            "QT prolongation"
        ],
        "interactions": "CNS depressants additive effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "domperidone",
        "name": "Domperidone",
        "pharmacologicClass": "prokinetic-agents",
        "therapeuticClass": "gastrointestinal-motility",
        "system": "gastrointestinal-system",
        "mechanism": "Enhance GI motility through various receptor mechanisms.",
        "features": "Peripheral D2 antagonist.",
        "clinicalChoice": "Gastroparesis (not FDA approved in US).",
        "indications": [
            "Gastroparesis"
        ],
        "contraindications": [
            "Cardiac Arrhythmias"
        ],
        "sideEffects": [
            "Extrapyramidal effects",
            "Tardive dyskinesia",
            "QT prolongation"
        ],
        "interactions": "CNS depressants additive effects.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "loperamide",
        "name": "Loperamide",
        "pharmacologicClass": "antidiarrheals",
        "therapeuticClass": "gastrointestinal-motility",
        "system": "gastrointestinal-system",
        "mechanism": "Reduce intestinal motility and fluid secretion.",
        "features": "Opioid receptor agonist, poor CNS penetration.",
        "clinicalChoice": "Acute diarrhea, IBS-D.",
        "indications": [
            "Acute Diarrhea",
            "IBS with Diarrhea"
        ],
        "contraindications": [
            "Bloody Diarrhea",
            "C. diff Colitis"
        ],
        "sideEffects": [
            "Constipation",
            "CNS depression",
            "Dependency potential"
        ],
        "interactions": "MAOIs contraindicated with loperamide.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "diphenoxylate-atropine",
        "name": "Diphenoxylate/Atropine",
        "pharmacologicClass": "antidiarrheals",
        "therapeuticClass": "gastrointestinal-motility",
        "system": "gastrointestinal-system",
        "mechanism": "Reduce intestinal motility and fluid secretion.",
        "features": "Opioid with anticholinergic to prevent abuse.",
        "clinicalChoice": "Chronic diarrhea.",
        "indications": [
            "Chronic Diarrhea"
        ],
        "contraindications": [
            "Pseudomembranous Colitis"
        ],
        "sideEffects": [
            "Constipation",
            "CNS depression",
            "Dependency potential"
        ],
        "interactions": "MAOIs contraindicated with loperamide.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "psyllium",
        "name": "Psyllium",
        "pharmacologicClass": "laxatives",
        "therapeuticClass": "gastrointestinal-motility",
        "system": "gastrointestinal-system",
        "mechanism": "Various mechanisms to promote bowel movements.",
        "features": "Bulk-forming fiber.",
        "clinicalChoice": "Chronic constipation, IBS.",
        "indications": [
            "Constipation",
            "IBS"
        ],
        "contraindications": [
            "GI Obstruction"
        ],
        "sideEffects": [
            "Electrolyte imbalances",
            "Dependency",
            "Dehydration"
        ],
        "interactions": "May affect absorption of other drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "docusate",
        "name": "Docusate",
        "pharmacologicClass": "laxatives",
        "therapeuticClass": "gastrointestinal-motility",
        "system": "gastrointestinal-system",
        "mechanism": "Various mechanisms to promote bowel movements.",
        "features": "Stool softener.",
        "clinicalChoice": "Prevention of constipation.",
        "indications": [
            "Constipation Prevention"
        ],
        "contraindications": [
            "GI Obstruction"
        ],
        "sideEffects": [
            "Electrolyte imbalances",
            "Dependency",
            "Dehydration"
        ],
        "interactions": "May affect absorption of other drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "senna",
        "name": "Senna",
        "pharmacologicClass": "laxatives",
        "therapeuticClass": "gastrointestinal-motility",
        "system": "gastrointestinal-system",
        "mechanism": "Various mechanisms to promote bowel movements.",
        "features": "Stimulant laxative.",
        "clinicalChoice": "Acute constipation.",
        "indications": [
            "Acute Constipation"
        ],
        "contraindications": [
            "GI Obstruction",
            "Inflammatory Bowel Disease"
        ],
        "sideEffects": [
            "Electrolyte imbalances",
            "Dependency",
            "Dehydration"
        ],
        "interactions": "May affect absorption of other drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "mesalamine",
        "name": "Mesalamine",
        "pharmacologicClass": "aminosalicylates",
        "therapeuticClass": "inflammatory-bowel-disease",
        "system": "gastrointestinal-system",
        "mechanism": "Deliver 5-aminosalicylic acid to inflamed colonic mucosa to inhibit prostaglandins and leukotrienes.",
        "features": "Multiple formulations for targeted release.",
        "clinicalChoice": "Mild to moderate ulcerative colitis maintenance.",
        "indications": [
            "Ulcerative Colitis"
        ],
        "contraindications": [
            "Salicylate Allergy"
        ],
        "sideEffects": [
            "Headache",
            "Nausea",
            "Interstitial nephritis (rare)"
        ],
        "interactions": "Concurrent NSAIDs increase renal risk.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "infliximab",
        "name": "Infliximab",
        "pharmacologicClass": "biologic-agents",
        "therapeuticClass": "inflammatory-bowel-disease",
        "system": "gastrointestinal-system",
        "mechanism": "Monoclonal antibodies neutralize TNF-α to reduce intestinal inflammation.",
        "features": "Chimeric anti-TNF antibody. | Chimeric monoclonal antibody against TNF-α.",
        "clinicalChoice": "Moderate to severe Crohn disease or ulcerative colitis.",
        "indications": [
            "Crohn Disease",
            "Rheumatoid Arthritis",
            "Ulcerative Colitis"
        ],
        "contraindications": [
            "Active Infection",
            "Latent TB without prophylaxis"
        ],
        "sideEffects": [
            "Infection risk",
            "Infusion reactions",
            "Reactivation of latent TB"
        ],
        "interactions": "Live vaccines contraindicated.",
        "interactionDetails": "",
        "pageType": "drug",
        "pharmacologicClasses": [
            "biologic-agents",
            "biologic-dmards"
        ]
    },
    {
        "id": "octreotide",
        "name": "Octreotide",
        "pharmacologicClass": "somatostatin-analogs",
        "therapeuticClass": "portal-and-hepatic-disorders",
        "system": "gastrointestinal-system",
        "mechanism": "Decrease splanchnic blood flow and hormone secretion.",
        "features": "Long-acting somatostatin analog.",
        "clinicalChoice": "Variceal bleeding control, hormone-secreting tumors.",
        "indications": [
            "Esophageal Varices",
            "Carcinoid Syndrome",
            "VIPoma"
        ],
        "contraindications": [
            "Hypersensitivity"
        ],
        "sideEffects": [
            "Gallstones",
            "Steatorrhea",
            "Glucose dysregulation"
        ],
        "interactions": "May reduce absorption of fat-soluble drugs.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "lactulose",
        "name": "Lactulose",
        "pharmacologicClass": "ammonia-lowering-agents",
        "therapeuticClass": "portal-and-hepatic-disorders",
        "system": "gastrointestinal-system",
        "mechanism": "Reduce intestinal ammonia production and absorption.",
        "features": "Non-absorbable disaccharide acidifying colon.",
        "clinicalChoice": "First-line therapy for hepatic encephalopathy.",
        "indications": [
            "Hepatic Encephalopathy"
        ],
        "contraindications": [
            "Galactosemia"
        ],
        "sideEffects": [
            "Bloating",
            "Diarrhea",
            "Electrolyte disturbances"
        ],
        "interactions": "Additive diarrhea with other laxatives.",
        "interactionDetails": "",
        "pageType": "drug"
    },
    {
        "id": "rifaximin",
        "name": "Rifaximin",
        "pharmacologicClass": "ammonia-lowering-agents",
        "therapeuticClass": "portal-and-hepatic-disorders",
        "system": "gastrointestinal-system",
        "mechanism": "Reduce intestinal ammonia production and absorption.",
        "features": "Poorly absorbed oral antibiotic.",
        "clinicalChoice": "Adjunct to lactulose to reduce ammonia-producing flora.",
        "indications": [
            "Hepatic Encephalopathy"
        ],
        "contraindications": [
            "Severe Hepatic Impairment (caution)"
        ],
        "sideEffects": [
            "Bloating",
            "Diarrhea",
            "Electrolyte disturbances"
        ],
        "interactions": "Additive diarrhea with other laxatives.",
        "interactionDetails": "",
        "pageType": "drug"
    }

];export default drugs;
